Brain Tumor
📧 Sign up to get email alerts when something new happens for Brain Tumor.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2010-12-20FDA Approved: MULTIHANCE — Supplemental Application (BRACCO DIAGNOSTICS INC)
The FDA approved a supplemental application for MULTIHANCE (gadobenate dimeglumine) to update its labeling and imaging indications.